GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,485,000 | +62.4% | 142,305 | +63.4% | 6.23% | +11.4% |
| Q1 2019 | $4,610,000 | -49.3% | 87,099 | -60.7% | 5.60% | +49.2% |
| Q4 2018 | $9,099,000 | -56.4% | 221,662 | -59.6% | 3.75% | -6.2% |
| Q3 2018 | $20,871,000 | +14.3% | 549,231 | +35.9% | 4.00% | +41.4% |
| Q2 2018 | $18,265,000 | +20.0% | 404,092 | +28.2% | 2.83% | +12.8% |
| Q1 2018 | $15,222,000 | +24.2% | 315,147 | +1.2% | 2.51% | +10.9% |
| Q4 2017 | $12,258,000 | +46.2% | 311,516 | +15.3% | 2.26% | +4.8% |
| Q3 2017 | $8,386,000 | -9.8% | 270,075 | -20.6% | 2.16% | -46.8% |
| Q2 2017 | $9,302,000 | +23.4% | 340,100 | +66.3% | 4.05% | +5.4% |
| Q1 2017 | $7,536,000 | +769.2% | 204,500 | +240.8% | 3.85% | +657.1% |
| Q4 2016 | $867,000 | – | 60,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |